Mesoblast, founded by Dr. Silviu Itescu in 2004, is currently seeking product approval and market access in Europe while trading on the Nasdaq stock exchange.

The entities involved

• Mesoblast →

  pharmaceutical company

  • Trump pledged to unleash American oil and gas production.Sun 15:33
  • Mesoblast is seeking FDA review of the BLA for its product rexlemestrocel-L.Thu 12:51
• Europe →

  terrestrial continent located in north-western Eurasia

  • The European Commission aims to strengthen homegrown AI capabilities while global advanced models face usage restrictions.Mon 17:49
  • The European Central Bank is forced to raise interest rates due to energy price shocks from the Iran war and an influx of Chinese exports.Mon 17:49
• Nasdaq →

  American fully electronic stock exchange

  • Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
  • Vanguard Short-Term Inflation-Protected Securities ETF is disclosing its holdings to the SEC and trading on the Nasdaq electronic stock exchange.Mon 16:28

Related events

• Products launched in the market in Europe starting on July 1st.Jul 9
• Investor groups, including Index Ventures and Accel, are urging support for EU Inc. law to enhance Europe's competitiveness.Sep 11
• Bio-Techne operates in European, US, and Middle Eastern markets and is listed on NASDAQ.Sep 22